Dr Steve Stice and Human Stem Cells
I am pleased and honored for the privilege of profiling Dr. Steve Stice. He has a history of working in areas that are Biotechnology Headliners…from cloning to stem cells. Here I will be focusing on his current work with Human Stem Cells and Neural Progenitors at ArunA Biomedical and [...]
Dr. Steve Stice is in the on deck circle. We will be featuring his work in developing neural stem cell based assays for use in drug discovery. These platforms have the potential to help more efficiently and accuratelyidentify targets for pain, neurodegeneration and other CNS and PNS related diseases.
As a back drop, we wanted to [...]
The use of Human Embryonic Stem Cells in Research is a lightening rod. It is catalyzing a great debate that transcends science and instead challenges us to take positions based on morality and ethics.
My considerations are humble. They do not extend to the potential of manipulating pluripotent cells to grow transplantable human tissues and organs [...]
15.07.2008 13:34
Dicerna Pharmaceuticals, a Second Generation RNA Interference Company, Completes Second Closing of Series A Financing; Unveils Strategic Focus
Dicerna Pharmaceuticals, Inc. (www.dicerna.com), an RNA interference company developing novel therapeutics utilizing proprietary Dicer Substrate Technology™, today announced a second closing of its Series A financing, receiving a total of $8.4 million in additional venture capital [...]
